Publicacións en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (4)

2024

  1. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

    Archivos de Bronconeumologia, Vol. 60, Núm. 7, pp. 417-422

2022

  1. Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial

    International journal of chronic obstructive pulmonary disease, Vol. 17, pp. 3097-3109

2021

  1. Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain

    Journal of Medical Economics, Vol. 24, Núm. 1, pp. 874-882

2020

  1. Cost-effectiveness analysis of a once-daily single-inhaler triple therapy for patients with chronic obstructive pulmonary disease (COPD) using the fulfil trial: A Spanish perspective

    International Journal of COPD, Vol. 15, pp. 1621-1632